Technology
Health
Biotechnology

Proteon Therapeutics

$3.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (2.71%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PRTO and other stocks, options, ETFs, and crypto commission-free!

About

Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. Read More The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.

Employees
17
Headquarters
Waltham, Massachusetts
Founded
2001
Market Cap
63.89M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
69.17K
High Today
$3.51
Low Today
$3.16
Open Price
$3.32
Volume
173.96K
52 Week High
$3.94
52 Week Low
$1.50

Collections

Technology
Health
Biotechnology
Therapy
Research And Development
Biopharmaceutical
Pharmaceutical
2014 IPO

News

Seeking AlphaMar 14

Proteon files for stock offering; shares down 4% after hours

Proteon Therapeutics (NASDAQ:PRTO) has filed a preliminary prospectus for an unspecified stock offering. Shares are down 4% after hours....

129
Yahoo FinanceMar 13

Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results

WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its financial results for the year ended December 31, 2018, and recent business highlights. “We are looking forward to the expected release this month of top-line results from PATENCY-2, our second Phase 3 clinical trial of investigational vonapanitase,” said Timothy Noye...

34
Simply Wall StMar 8

How Does Investing In Proteon Therapeutics, Inc. (NASDAQ:PRTO) Impact The Volatility Of Your Portfolio?

Anyone researching Proteon Therapeutics, Inc. (NASDAQ:PRTO) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. First, we have company specific volatility, which is the price gyrations of an individual stock. Holding at least 8 stocks can reduce this kind of risk across a portfolio. The second type is the broader market volatility, which you canno...

142

Earnings

-$0.70
-$0.55
-$0.40
-$0.25
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.26 per share
Actual
-$0.27 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.